This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Biosense Webster (Israel) Ltd.. Active years: 2022-2026.
Company Filing History:
Years Active: 2022-2026
Title: Vincent Alexandre Roger: Innovator in Cardiac Technology
Introduction
Vincent Alexandre Roger is a notable inventor based in Caluire-et-Cuire, France. He has made significant contributions to the field of cardiac technology, particularly through his innovative patent that addresses the identification of abnormal LAT differences in heart chambers.
Latest Patents
Vincent holds a patent for an apparatus designed for automatic identification of abnormal LAT differences. This apparatus consists of a catheter that can be inserted into a chamber of the heart. It is equipped with one or more electrodes that contact myocardial tissue at multiple locations within the chamber. The electrodes receive electrical signals that are responsive to a conduction wave traveling through the tissue. The apparatus includes a display and a processor that processes these electrical signals to render a map of the chamber. This map indicates the local times of occurrence of the conduction wave at various locations. Additionally, the processor calculates the velocity of the conduction wave between these locations and marks areas where the velocity falls below a preset threshold.
Career Highlights
Vincent is currently employed at Biosense Webster Ltd., a company known for its advancements in cardiac mapping and ablation technologies. His work focuses on improving the accuracy and efficiency of cardiac procedures, which can significantly enhance patient outcomes.
Collaborations
Vincent collaborates with talented professionals in his field, including Natan Sharon Katz and Benjamin Cohen. Their combined expertise contributes to the innovative solutions developed at Biosense Webster.
Conclusion
Vincent Alexandre Roger is a pioneering inventor whose work in cardiac technology is making a difference in the medical field. His patent for an advanced apparatus demonstrates his commitment to improving heart health through innovation.